MackTrack Inc. – Trademark Portfolio
Entity Type: 03
MackTrack Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 4 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include CONSUELO MACK WEALTHTRACK and THE RIGHT TRACK TO YOUR FINANCIAL HEALTH. The owner is based in New York, NY.
1350 Sixth Avenue, Suite 280
New York, NY 10019
Showing of trademarks Trademarks
Trademark Classifications
MackTrack Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does MackTrack Inc. have?
MackTrack Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned.
What trademark classes does MackTrack Inc. file in?
MackTrack Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 36 (Insurance & Financial), Class 16 (Paper Goods). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are MackTrack Inc.'s most well-known trademarks?
MackTrack Inc.'s registered trademark portfolio includes well-known marks such as CONSUELO MACK WEALTHTRACK and THE RIGHT TRACK TO YOUR FINANCIAL HEALTH. These are among 4 currently registered trademarks in the portfolio.
What is MackTrack Inc.'s trademark registration success rate?
MackTrack Inc. has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.